Henry Schein, Inc. (HSIC) Given Average Rating of “Hold” by Analysts
Henry Schein, Inc. (NASDAQ:HSIC) has been assigned an average rating of “Hold” from the seventeen research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, ten have issued a hold rating and six have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $93.25.
A number of brokerages have recently issued reports on HSIC. Credit Suisse Group reissued a “hold” rating and set a $80.00 price objective on shares of Henry Schein in a research report on Thursday, July 13th. Jefferies Group LLC reissued a “hold” rating and set a $89.00 price objective on shares of Henry Schein in a research report on Friday, October 20th. Royal Bank Of Canada began coverage on shares of Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective for the company. Morgan Stanley began coverage on shares of Henry Schein in a research report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price objective for the company. Finally, BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd.
Shares of Henry Schein (NASDAQ HSIC) opened at $77.64 on Friday. Henry Schein has a 1 year low of $73.61 and a 1 year high of $93.50. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.85 and a current ratio of 1.55. The stock has a market cap of $12,275.82, a price-to-earnings ratio of 21.96, a PEG ratio of 2.08 and a beta of 1.03.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the previous year, the firm posted $0.82 EPS. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. sell-side analysts forecast that Henry Schein will post 3.64 earnings per share for the current year.
Henry Schein declared that its Board of Directors has authorized a stock repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/05/henry-schein-inc-hsic-given-average-rating-of-hold-by-analysts.html.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.19% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in HSIC. Wellington Management Group LLP boosted its holdings in shares of Henry Schein by 116.0% during the 1st quarter. Wellington Management Group LLP now owns 13,386 shares of the company’s stock valued at $2,275,000 after purchasing an additional 7,189 shares during the last quarter. Teachers Advisors LLC boosted its holdings in shares of Henry Schein by 3.3% during the 1st quarter. Teachers Advisors LLC now owns 145,772 shares of the company’s stock valued at $24,777,000 after purchasing an additional 4,595 shares during the last quarter. Thrivent Financial For Lutherans boosted its holdings in shares of Henry Schein by 2.8% during the 1st quarter. Thrivent Financial For Lutherans now owns 2,890 shares of the company’s stock valued at $491,000 after purchasing an additional 80 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Henry Schein by 0.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 310,134 shares of the company’s stock valued at $52,714,000 after purchasing an additional 1,831 shares during the last quarter. Finally, Capital One National Association boosted its holdings in shares of Henry Schein by 0.6% during the 2nd quarter. Capital One National Association now owns 42,835 shares of the company’s stock valued at $7,840,000 after purchasing an additional 273 shares during the last quarter. 47.48% of the stock is owned by institutional investors and hedge funds.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.